Aurobindo Pharma’s Rivaroxaban Tablets get U.S FDA nod
Generic drugmaker Aurobindo Pharma has obtained last approval from the U.S. Meals and Drug Administration (U.S. FDA) to fabricate and market Rivaroxaban Tablets USP, 2.5 mg. The authorised product is bioequivalent and therapeutically equal to the reference listed drug Xarelto 2.5 mg of Janssen Prescription drugs Inc., the Hyderabad-headquartered firm mentioned on Saturday. It plans to launch…